EE200000018A - 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine - Google Patents
6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamineInfo
- Publication number
- EE200000018A EE200000018A EEP200000018A EEP200000018A EE200000018A EE 200000018 A EE200000018 A EE 200000018A EE P200000018 A EEP200000018 A EE P200000018A EE P200000018 A EEP200000018 A EE P200000018A EE 200000018 A EE200000018 A EE 200000018A
- Authority
- EE
- Estonia
- Prior art keywords
- ylpyridines
- pyrrolidin
- preparation
- therapeutic use
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9708706A FR2765874B1 (fr) | 1997-07-09 | 1997-07-09 | Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique |
PCT/FR1998/001446 WO1999002517A1 (fr) | 1997-07-09 | 1998-07-07 | Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200000018A true EE200000018A (et) | 2000-08-15 |
Family
ID=9509040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200000018A EE200000018A (et) | 1997-07-09 | 1998-07-07 | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine |
Country Status (21)
Country | Link |
---|---|
US (1) | US6184229B1 (sk) |
EP (1) | EP1000056A1 (sk) |
JP (1) | JP2002508004A (sk) |
KR (1) | KR20010021617A (sk) |
CN (1) | CN1262680A (sk) |
AR (1) | AR013192A1 (sk) |
AU (1) | AU8544498A (sk) |
BG (1) | BG104037A (sk) |
BR (1) | BR9811672A (sk) |
CA (1) | CA2295666A1 (sk) |
CO (1) | CO4890850A1 (sk) |
EE (1) | EE200000018A (sk) |
FR (1) | FR2765874B1 (sk) |
HU (1) | HUP0003856A2 (sk) |
IL (1) | IL133536A0 (sk) |
NO (1) | NO20000066L (sk) |
PL (1) | PL338123A1 (sk) |
SK (1) | SK212000A3 (sk) |
TR (1) | TR200000057T2 (sk) |
WO (1) | WO1999002517A1 (sk) |
ZA (1) | ZA986047B (sk) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005126340A (ja) * | 2003-10-22 | 2005-05-19 | Kureha Chem Ind Co Ltd | 置換ピリドン類の製造法、その原料化合物及びその製造方法 |
JP5254616B2 (ja) | 2004-09-13 | 2013-08-07 | クロノ セラピューティクス、インコーポレイテッド | 生物学的同調性(biosynchronous)経皮的薬物送達 |
CA2682323A1 (en) | 2007-04-02 | 2008-10-09 | Parkinson's Institute | Methods and compositions for reduction of side effects of therapeutic treatments |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
WO2018129304A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
AU2019279884A1 (en) | 2018-05-29 | 2020-12-10 | Morningside Venture Investments Limited | Drug delivery methods and systems |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5227391A (en) * | 1992-04-10 | 1993-07-13 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5232933A (en) * | 1992-05-21 | 1993-08-03 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
-
1997
- 1997-07-09 FR FR9708706A patent/FR2765874B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-07 WO PCT/FR1998/001446 patent/WO1999002517A1/fr not_active Application Discontinuation
- 1998-07-07 KR KR1020007000175A patent/KR20010021617A/ko not_active Application Discontinuation
- 1998-07-07 AU AU85444/98A patent/AU8544498A/en not_active Abandoned
- 1998-07-07 JP JP50824799A patent/JP2002508004A/ja active Pending
- 1998-07-07 HU HU0003856A patent/HUP0003856A2/hu unknown
- 1998-07-07 US US09/462,352 patent/US6184229B1/en not_active Expired - Fee Related
- 1998-07-07 BR BR9811672-0A patent/BR9811672A/pt not_active IP Right Cessation
- 1998-07-07 PL PL98338123A patent/PL338123A1/xx unknown
- 1998-07-07 TR TR2000/00057T patent/TR200000057T2/xx unknown
- 1998-07-07 EE EEP200000018A patent/EE200000018A/xx unknown
- 1998-07-07 IL IL13353698A patent/IL133536A0/xx unknown
- 1998-07-07 SK SK21-2000A patent/SK212000A3/sk unknown
- 1998-07-07 CN CN98807003A patent/CN1262680A/zh active Pending
- 1998-07-07 CA CA002295666A patent/CA2295666A1/en not_active Abandoned
- 1998-07-07 EP EP98936453A patent/EP1000056A1/fr not_active Withdrawn
- 1998-07-08 AR ARP980103305A patent/AR013192A1/es not_active Application Discontinuation
- 1998-07-08 ZA ZA986047A patent/ZA986047B/xx unknown
- 1998-07-08 CO CO98038696A patent/CO4890850A1/es unknown
-
1999
- 1999-12-22 BG BG104037A patent/BG104037A/xx unknown
-
2000
- 2000-01-06 NO NO20000066A patent/NO20000066L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA986047B (en) | 1999-02-01 |
AR013192A1 (es) | 2000-12-13 |
FR2765874B1 (fr) | 1999-08-13 |
HUP0003856A2 (hu) | 2001-10-28 |
PL338123A1 (en) | 2000-09-25 |
CN1262680A (zh) | 2000-08-09 |
WO1999002517A1 (fr) | 1999-01-21 |
CO4890850A1 (es) | 2000-02-28 |
JP2002508004A (ja) | 2002-03-12 |
CA2295666A1 (en) | 1999-01-21 |
US6184229B1 (en) | 2001-02-06 |
FR2765874A1 (fr) | 1999-01-15 |
BG104037A (en) | 2001-04-30 |
AU8544498A (en) | 1999-02-08 |
BR9811672A (pt) | 2000-09-19 |
TR200000057T2 (tr) | 2000-08-21 |
NO20000066L (no) | 2000-03-09 |
KR20010021617A (ko) | 2001-03-15 |
IL133536A0 (en) | 2001-04-30 |
EP1000056A1 (fr) | 2000-05-17 |
NO20000066D0 (no) | 2000-01-06 |
SK212000A3 (en) | 2000-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT911340E (pt) | Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos | |
NL300295I2 (nl) | 3,3-diarylpropylaminen, de toepassing en bereidinghiervan | |
EE200000658A (et) | CD23 antikehad, nende derivaadid ja nende terapeutiline kasutamine | |
ID24118A (id) | Terapi gabungan | |
EE04151B1 (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena | |
PT869126E (pt) | Derivados de ditiolano, sua preparacao e seus efeitos terapeuticos | |
DE69529598D1 (de) | Arzneimittelenthaltende Manschette | |
EE200200160A (et) | 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid | |
ID22878A (id) | Komposisi aktif secara terapi | |
EE200100470A (et) | Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
EE200000621A (et) | Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine | |
LV12624A (lv) | Thienylazolylalcoxyethanamines their preparation and their application as medicaments | |
ID24275A (id) | Terapi kombinasi | |
FI944600A (fi) | Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa | |
EE200000094A (et) | Uued plokk-kopolümeerid ja nende saamine | |
FI956298A0 (fi) | 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö | |
EE9700288A (et) | Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis | |
NO992676D0 (no) | 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse | |
DK1025100T3 (da) | 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf | |
EE03690B1 (et) | Imidasopüridasiinid, neid sisaldav ravim ja nendekasutamine | |
EE200000207A (et) | 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
EE9800333A (et) | Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias | |
EE200000018A (et) | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine | |
FI956251A (fi) | 1-okso-2-(fenyylisulfonyyliamino)pentyylipiperidiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
FI971317A0 (fi) | Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö |